UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Attenuated Psychosis Syndrome: Ready for DSM-5.1?

Annual review of clinical psychology, 2014-01, Vol.10 (1), p.155-192

2014

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychological status of subjects at high risk for a first episode of psychosis

Schizophrenia research, 2004-04, Vol.67 (2), p.115-122

2004

Link zum Volltext

Verfügbarkeit prüfen

Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis

Psychological medicine, 2023-04, Vol.53 (6), p.2399-2408

2023

Link zum Volltext

Verfügbarkeit prüfen

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study

Schizophrenia research, 2021-01, Vol.227, p.28-37

2021

Link zum Volltext

Verfügbarkeit prüfen

NAPLS: SOCIAL FUNCTIONING FOUND TO BE A STABLE TRAIT AND A PREDICTOR OF PSYCHOSIS

Schizophrenia research, 2008, Vol.102 (1), p.24-24

2008

Link zum Volltext

Verfügbarkeit prüfen

126 – Persistent drug abuse in first episode psychosis – 1- and 2-year outcome

Schizophrenia research, 2008-02, Vol.98, p.85-85

2008

Link zum Volltext

Verfügbarkeit prüfen

Six-year prospective study of major depressive disorder: Remissions, relapses, and the effects of personality disorders

European psychiatry, 2007-03, Vol.22, p.S24-S25

2007

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis

Schizophrenia research, 2019-02, Vol.204, p.334-336

2019

Link zum Volltext

Verfügbarkeit prüfen

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. Study rationale and design

Schizophrenia research, 2003-05, Vol.61 (1), p.7-18

2003

Link zum Volltext

Verfügbarkeit prüfen

Factorial structure of the Scale of Prodromal Symptoms

Schizophrenia research, 2004-06, Vol.68 (2), p.339-347

2004

Link zum Volltext

Verfügbarkeit prüfen

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

Schizophrenia research, 2003-05, Vol.61 (1), p.7-18

2003

Link zum Volltext

Verfügbarkeit prüfen

PROD-screen - a screen for prodromal symptoms of psychosis

International journal of methods in psychiatric research, 2003-06, Vol.12 (2), p.92-104

2003

Link zum Volltext

Verfügbarkeit prüfen

Abnormal sensory registration, deviance detection, and attention allocation in the schizophrenia prodrome

International journal of psychophysiology, 2008-09, Vol.69 (3), p.186-187

2008

Link zum Volltext

Verfügbarkeit prüfen

0439 FRONTO-TEMPORAL CORTICAL DYSFUNCTION DURING ATTENTION AND WORKING MEMORY FMRI TASKS IN PRODROMAL AND EARLY ILLNESS SCHIZOPHRENIA

Schizophrenia research, 2006-10, Vol.86, p.S76-S76

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment of schizophrenia

The Lancet (British edition), 1995-09, Vol.346 (8978), p.820-825

1995

Link zum Volltext

Verfügbarkeit prüfen

Natural course of schizophrenic illness: Deterioration versus continuation of premorbid function

European neuropsychopharmacology, 1996-06, Vol.6, p.221-221

McGlashan, T.H.

1996

Link zum Volltext

Verfügbarkeit prüfen

The borderline personality disorder practice guidelines: the good, the bad, and the realistic

Journal of personality disorders, 2002-04, Vol.16 (2), p.119

McGlashan, T H

2002

Link zum Volltext

Verfügbarkeit prüfen

WC8A THE CRITERIA OF PRODROMAL SYNDROMES AND ALTERNATE PRODROMAL DIAGNOSTIC CRITERIA IN NAPLS

Schizophrenia research, 2006-10, Vol.86, p.S17-S17

2006

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and symptom assessment in the schizophrenia prodrome

Schizophrenia research, 2003-03, Vol.60 (1), p.6-7

2003

Link zum Volltext

Verfügbarkeit prüfen

Neurocognitive dimensions characterizing first-time psychotic patients

European psychiatry, 2002-05, Vol.17, p.54-54

2002

Link zum Volltext

Verfügbarkeit prüfen

Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results

Schizophrenia research, 2003-03, Vol.60 (1), p.295-295

2003

Link zum Volltext

Verfügbarkeit prüfen

Olanzapine versus placebo for prodromal symptoms

Schizophrenia research, 2003-03, Vol.60 (1), p.306-307

2003

Link zum Volltext

Verfügbarkeit prüfen

Natural history of the deficit syndrome

Schizophrenia research, 1993-04, Vol.9 (2), p.98-98

1993

Link zum Volltext

Verfügbarkeit prüfen

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

Schizophrenia research, 2003-05, Vol.61 (1), p.19-30

2003

Link zum Volltext

Verfügbarkeit prüfen

Testing systems for assessment of negative symptoms in schizophrenia

Schizophrenia research, 1991-05, Vol.4 (3), p.256-256

1991

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(32)

Sprache

Erscheinungsjahr

n.n

Thema

Psychiatry
(11)
Humans
(10)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Psychosis
(7)
Schizophrenia
(7)
Adolescent
(5)
Adult
(5)
Female
(5)
Male
(5)
Biological And Medical Sciences
(4)
Medical Sciences
(4)
Prodromal Symptoms
(4)
Psychology. Psychoanalysis. Psychiatry
(4)
Psychopathology. Psychiatry
(4)
Psychotic Disorders - Diagnosis
(4)
Psychotic Disorders - Psychology
(4)
Antipsychotic Agents - Therapeutic Use
(3)
Longitudinal Studies
(3)
Psychiatry And Mental Health
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Attenuated Psychosis Syndrome: Ready for DSM-5.1?

Neuropsychological status of subjects at high risk for a first episode of psychosis

Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis

Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study

NAPLS: SOCIAL FUNCTIONING FOUND TO BE A STABLE TRAIT AND A PREDICTOR OF PSYCHOSIS

126 – Persistent drug abuse in first episode psychosis – 1- and 2-year outcome

Six-year prospective study of major depressive disorder: Remissions, relapses, and the effects of personality disorders

Longitudinal changes in social cognition in individuals at clinical high risk for psychosis: An outcome based analysis

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. Study rationale and design

Factorial structure of the Scale of Prodromal Symptoms

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

PROD-screen - a screen for prodromal symptoms of psychosis

Abnormal sensory registration, deviance detection, and attention allocation in the schizophrenia prodrome

0439 FRONTO-TEMPORAL CORTICAL DYSFUNCTION DURING ATTENTION AND WORKING MEMORY FMRI TASKS IN PRODROMAL AND EARLY ILLNESS SCHIZOPHRENIA

Treatment of schizophrenia

Natural course of schizophrenic illness: Deterioration versus continuation of premorbid function

The borderline personality disorder practice guidelines: the good, the bad, and the realistic

WC8A THE CRITERIA OF PRODROMAL SYNDROMES AND ALTERNATE PRODROMAL DIAGNOSTIC CRITERIA IN NAPLS

Diagnosis and symptom assessment in the schizophrenia prodrome

Neurocognitive dimensions characterizing first-time psychotic patients

Olanzapine versus placebo treatment of the schizophrenia prodrome: One year results

Olanzapine versus placebo for prodromal symptoms

Natural history of the deficit syndrome

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

Testing systems for assessment of negative symptoms in schizophrenia

Suchergebnisse filtern